TopNewsOn
Health

STAT+: Pharmalittle: We’re reading about payments to Russian middlemen, a possible Dupixent rival, and more

Ed Silverman·STAT News·November 2, 2026

Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian government entities

Read the full story at STAT News →